Search for: "Wyeth Pharmaceuticals"
Results 661 - 680
of 971
Sorted by Relevance
|
Sort by Date
30 Dec 2013, 5:25 am
Wyeth Pharmaceuticals, ___ F.3d ___, 2013 WL 6224337 (6th Cir. [read post]
12 Feb 2015, 12:56 pm
Medicis Pharmaceutical Corp., 2015 Ariz. [read post]
5 Nov 2014, 4:00 am
For the moment, let's put aside the fact that Vermont gave us Wyeth v. [read post]
3 Jan 2012, 10:20 am
Wyeth LLC, 131 S. [read post]
1 May 2008, 11:21 am
One of the ways we feed this blog is doing what comes naturally to us lawyers - reading recent cases - and hoping that something inspires us. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
10 Oct 2008, 11:32 am
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) - US: Trial judge grants permanent injunction in case relating to recombinant erythropoietin (EPO) patent: Amgen v… [read post]
15 Jul 2009, 5:15 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: European Commission Competition DG releases final report on pharmaceutical sector (IPKat) (PatLit) (BLOG@IP::JUR) (IAM) (Managing Intellectual Property) (Intellectual Property Watch) (The SPC Blog) (IAM) US: Follow-on biologics proposals considered by US Senate HELP Committee; Committee passes amendment for 12-year biologics exclusivity period… [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
6 Feb 2009, 5:00 am
(IP finance) Pharmaceutical Technology article on barriers to entry for generic pharma companies based in emerging economies (Afro-IP) The effects of IP protection on agricultural research: Patents are not the problem – response to Nature Biotechnology article ‘Patents Versus Patenting: Implications of Intellectual Property Protection for Biological Research’ (Patent Docs) SPC seminar – a brief report (The SPC Blog) (The SPC Blog) Ruminations on the… [read post]
30 Mar 2016, 8:00 am
Supreme Court decision in Wyeth v. [read post]
6 Jan 2007, 7:34 am
" For example, "the venom of a deadly sea snail found off the coast of the Philippines led Elan Pharmaceuticals Inc. to develop the painkiller Prialt, which U.S. regulators approved in 2004. [read post]
22 Aug 2008, 1:21 pm
L. art. 5 (2006), available at http://www.bepress.com/jtl/vol1/iss1/art5/ (link).It's nice to see him make it again, particularly with Wyeth v. [read post]
12 May 2008, 2:46 pm
Looking forward, in October 2008 (what will likely still be) the same Supreme Court hears oral arguments in the case Wyeth v. [read post]
12 Oct 2010, 8:26 am
Pharmaceutical companies responded with a threat - they would stop making vaccines unless federal lawmakers shielded them from liability. [read post]
28 Jan 2016, 1:15 pm
The Defendant’s Basis for Certiorari Johnson & Johnson argued that the Massachusetts state courts’ opinions had been contrary to a prior decision of the United States Supreme Court (Wyeth v. [read post]
29 Sep 2015, 8:41 am
Wyeth Pharmaceuticals, Inc. [read post]
19 Aug 2009, 5:41 am
(Patent Docs) US: BIO files amicus brief in Bilski (Patent Docs) US: Jim Greenwood on data exclusivity and healthcare innovation (BiotechBlog) (IP Watchdog) (Patent Docs) US: European biosimilars market may hint at limited US threat (GenericsWeb) US: Chris Hansen on the Myriad lawsuit (Patents4Life) Products Effexor (Venlafaxine) – US: Wyeth files suit alleging Alphapharm’s Enlafax infringes its Venlafaxine patent; Generic Health, which recently… [read post]
13 Nov 2009, 12:45 pm
Perhaps unsurprisingly, it didn’t take long for the discussion to go off the rails, thanks to panel member Daniel Troy, Chief Counsel at the FDA from 2001 to 2004, who prior to that, represented pharmaceutical and tobacco companies in cases against the agency, and who ultimately became one of the major architects behind the whole cockamamie version of preemption which had federal agencies protecting industry from liability rather than the other way around, and was… [read post]
21 Jan 2010, 1:00 am
(Patent Docs) Faslodex (Fulvestrant) - US: Infringement of US Patent following a Paragraph IV certification: AstraZeneca Pharmaceuticals LP et al. v. [read post]
